Compare HLXC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLXC | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.9M | 210.3M |
| IPO Year | N/A | N/A |
| Metric | HLXC | SRZN |
|---|---|---|
| Price | $10.17 | $26.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 12.1K | ★ 67.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.13 | $7.11 |
| 52 Week High | $10.35 | $29.60 |
| Indicator | HLXC | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 55.28 |
| Support Level | $10.14 | $23.63 |
| Resistance Level | $10.31 | $28.78 |
| Average True Range (ATR) | 0.09 | 2.26 |
| MACD | -0.00 | -0.17 |
| Stochastic Oscillator | 17.82 | 56.08 |
Helix Acquisition Corp III is a blank check company.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).